Description
- Source of omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health
- Helps support cognitive health and brain function
- Helps support the development of the brain, eyes and nerves in children up to 12 years of age
MaxSimil® Patented Lipid Absorption Enhancement Technology (PLATform) The MaxSimil PLATform is a novel monoglyceride delivery system that enhances absorption of lipid-based and lipid-soluble nutraceutical and food ingredients. This technology has been applied to XYMOGEN’s Omega MonoPure formulas in order to create a unique vehicle by which to deliver EPA and DHA.
Manufactured using MaxSimil® fish oil. MaxSimit® is a registered trademark of Ingenutra Inc. Protected under US patents 8,119,690 and 8,198,324; Canadian patents 2672513 and 2677670.
Exp: 12/2026
Supplement Facts
Medicinal Ingredients (per softgel)
MaxSimil® Fish oil (Engraulidae - Whole, Clupeidae - Whole): 1.3 g
600 mg eicosapentaenoic acid (EPA)
260 mg docosahexaenoic acid (DHA)
860 mg Omega-3 Fatty acids
Non-Medicinal Ingredients
Gelatin, glycerin, purified water, ethylcellulose, sodium alginate, medium chain triglycerides, oleic acid, stearic acid, ammonium hydroxide, mixed tocopherols concentrale.
Recently viewed
Disclaimer: The information and accompanying visuals should be used solely for informational purposes. Please note that the information provided on this website is not intended to replace professional medical advice, diagnosis, or treatment. Product descriptions and relevant nutritional information are supplied by the vendor.
Secure checkout
